Advertisement
UK markets close in 5 hours 15 minutes
  • FTSE 100

    8,095.38
    +55.00 (+0.68%)
     
  • FTSE 250

    19,726.13
    +6.76 (+0.03%)
     
  • AIM

    755.27
    +0.58 (+0.08%)
     
  • GBP/EUR

    1.1667
    +0.0022 (+0.19%)
     
  • GBP/USD

    1.2516
    +0.0054 (+0.43%)
     
  • Bitcoin GBP

    50,885.05
    -2,087.59 (-3.94%)
     
  • CMC Crypto 200

    1,361.69
    -20.88 (-1.51%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CRUDE OIL

    82.79
    -0.02 (-0.02%)
     
  • GOLD FUTURES

    2,337.50
    -0.90 (-0.04%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     
  • DAX

    17,983.60
    -105.10 (-0.58%)
     
  • CAC 40

    8,046.00
    -45.86 (-0.57%)
     

Sorrento Therapeutics' Slow-But-Steady Approach to COVID-19

Ji thinks the company's neutralizing antibodies are potentially more active than the frontrunners, which could help the biotech catch up and compete. Brian Orelli: We talked about a lot of different products. Henry Ji: Brian, our company has a lot of expertise, especially the antibodies space.